Safety and Effectiveness of Pegcetacoplan for Adults With Paroxysmal Nocturnal Hemoglobinuria: A Plain Language Summary of the First 48 Weeks of Study 307 (AAMDSIF 2023 PNH) - Apellis Medical Hub

Safety and Effectiveness of Pegcetacoplan for Adults With Paroxysmal Nocturnal Hemoglobinuria: A Plain Language Summary of the First 48 Weeks of Study 307

Share Via Email

PNH Congress Presentations Aplastic Anemia & MDS International Foundation (AAMDSIF) 2023

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.

Back to Conference Resources